Seller comparison · US self-pay prices

Fifty 410 vs Gimme Care: Which Is Cheaper? GLP-1 Prices Compared

Last updated

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    Fifty 410

    $199/4 weeks · about $213 per 30 days

  • Lowest price, compounded and not FDA-approved

    Gimme Care

    $160/28 days · about $171 per 30 days

The same medicines at sellers we link to

  • Compounded semaglutide, not FDA-approved: at a seller we link to

    Eden

    $99/mo · about $107 less per 30 days than Fifty 410

Fifty 410 and Gimme Care both sell compounded semaglutide injection and compounded tirzepatide injection. Compounded semaglutide injection: about $42 less per 30 days at Gimme Care: ≈ $171 per 30 days, against ≈ $213 per 30 days at Fifty 410. Compounded tirzepatide injection: about the same per 30 days: Fifty 410 ≈ $213 per 30 days, Gimme Care ≈ $213 per 30 days. Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026, Nov 13, 2026, and Nov 14, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Fifty 410 and Gimme Care charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price names the seller's own page it was read from.

Compounded semaglutide injection

Entry price: about $42 less per 30 days at Gimme Care: ≈ $171 per 30 days, against ≈ $213 per 30 days at Fifty 410. Top dose: about $42 less per 30 days at Gimme Care: ≈ $171 per 30 days at 2.4 mg, against ≈ $213 per 30 days at 2.4 mg at Fifty 410.

Fifty 410

Advertised entry price

$199/4 weeks (fifty410.com/pricing/semaglutide)

28-day supply (fifty410.com)

≈ $213.21 per 30 days at this quoted rate

Checked on fifty410.com

Compounded semaglutide via Fifty 410

Fifty 410 · seller's own price

4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price"

Price conditions

4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price"

Its page says "Administered as prescribed". Compounded; not FDA-approved.

28-day supply

Published maintenance dose

$199/4 weeks (fifty410.com/pricing/semaglutide)

28-day supply (fifty410.com)

≈ $213.21 per 30 days at this quoted rate

Checked on fifty410.com

At 2.4 mg

Compounded semaglutide via Fifty 410

Fifty 410 · seller's own price

4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price"

Price conditions

4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price"

Its page says "Administered as prescribed". Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 2.4 mg.

28-day supply

Gimme Care

Advertised entry price

$160/28 days (gimme.care/treatments/compounded-semaglutide)

28-day supply (gimme.care)

≈ $171.43 per 30 days at this quoted rate

Checked on gimme.care

Compounded semaglutide via Gimme Care

Gimme Care · seller's own price

month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included

Price conditions

month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included

Weekly injection. Subscriptions renew at the same frequency until cancelled; shipped medication is non-refundable. A video or audio visit is required first in Kansas, Louisiana, Mississippi, New Mexico and West Virginia. Compounded; not FDA-approved.

28-day supply

Published maintenance dose

$160/28 days (gimme.care/treatments/compounded-semaglutide)

28-day supply (gimme.care)

≈ $171.43 per 30 days at this quoted rate

Checked on gimme.care

At 2.4 mg

Compounded semaglutide via Gimme Care

Gimme Care · seller's own price

month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included

Price conditions

month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included

Weekly injection. Subscriptions renew at the same frequency until cancelled; shipped medication is non-refundable. A video or audio visit is required first in Kansas, Louisiana, Mississippi, New Mexico and West Virginia. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 2.4 mg.

28-day supply

Compounded tirzepatide injection

Entry price: about the same per 30 days: Fifty 410 ≈ $213 per 30 days, Gimme Care ≈ $213 per 30 days. Top dose: only Gimme Care publishes a top-dose price here: $199/28 days at 15 mg.

Fifty 410

Advertised entry price

$199/4 weeks (fifty410.com/pricing/tirzepatide)

28-day supply (fifty410.com)

≈ $213.21 per 30 days at this quoted rate

Checked on fifty410.com

Compounded tirzepatide via Fifty 410

Fifty 410 · seller's own price

4-week program, $199 total, available in all 50 states; an 8-week program is $299 total ($149.50 average per 4 weeks), not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota or Mississippi; medication, provider consultation and shipping included, no subscription or membership fees; pay only if a provider prescribes; "8-week program $299 $149.50 average per 4 weeks" ($149.50 per 4 weeks on the 8-week program, $299 total; "The $299 8-week tirzepatide program is not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota, or Mississippi.")

Price conditions

4-week program, $199 total, available in all 50 states; an 8-week program is $299 total ($149.50 average per 4 weeks), not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota or Mississippi; medication, provider consultation and shipping included, no subscription or membership fees; pay only if a provider prescribes; "8-week program $299 $149.50 average per 4 weeks" ($149.50 per 4 weeks on the 8-week program, $299 total; "The $299 8-week tirzepatide program is not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota, or Mississippi.")

Its page says "Administered as prescribed" on a "Clinician-guided" dose schedule. Until late October the page sold 3-month Starter, Mid-dose and High-dose programs ($399, $499 and $549); its pages now show only the 4- and 8-week programs. Compounded; not FDA-approved.

28-day supply

Published maintenance dose

No dose-specific quote tracked.

Gimme Care

Advertised entry price

$199/28 days (gimme.care/treatments/compounded-tirzepatide)

28-day supply (gimme.care)

≈ $213.21 per 30 days at this quoted rate

Checked on gimme.care

Compounded tirzepatide via Gimme Care

Gimme Care · seller's own price

its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in"

Price conditions

its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in"

Weekly injection. The tirzepatide page does not say how the 3 and 6 month plans are billed. Compounded; not FDA-approved.

28-day supply

Published maintenance dose

$199/28 days (gimme.care/treatments/compounded-tirzepatide)

28-day supply (gimme.care)

≈ $213.21 per 30 days at this quoted rate

Checked on gimme.care

At 15 mg

Compounded tirzepatide via Gimme Care

Gimme Care · seller's own price

its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in"

Price conditions

its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in"

Weekly injection. The tirzepatide page does not say how the 3 and 6 month plans are billed. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

28-day supply

Same medication, lower price

Cheaper than Fifty 410 and Gimme Care

Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.

Compounded, not FDA-approved

Compounded semaglutide

Lower than both. Gimme Care: $160/28 days, checked Nov 11, 2026 on gimme.care.

  1. Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
  3. Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
  4. Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer

Compounded, not FDA-approved

Compounded tirzepatide

Lower than both. Fifty 410: $199/4 weeks, checked Nov 13, 2026 on fifty410.com.

  1. Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
  3. Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
  4. Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)

Questions

Fifty 410 vs Gimme Care: common questions

Is Fifty 410 or Gimme Care cheaper for GLP-1 medication?

Compounded semaglutide injection: about $42 less per 30 days at Gimme Care: ≈ $171 per 30 days, against ≈ $213 per 30 days at Fifty 410. At the top published dose, about $42 less per 30 days at Gimme Care: ≈ $171 per 30 days at 2.4 mg, against ≈ $213 per 30 days at 2.4 mg at Fifty 410. Compounded tirzepatide injection: about the same per 30 days: Fifty 410 ≈ $213 per 30 days, Gimme Care ≈ $213 per 30 days. At the top published dose, only Gimme Care publishes a top-dose price here: $199/28 days at 15 mg. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Fifty 410 and Gimme Care sell FDA-approved GLP-1s or compounded versions?

Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Fifty 410 and Gimme Care prices include?

Fifty 410, compounded semaglutide injection: $199/4 weeks, 4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price". Gimme Care, compounded semaglutide injection: $160/28 days, month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included. Fifty 410, compounded tirzepatide injection: $199/4 weeks, 4-week program, $199 total, available in all 50 states; an 8-week program is $299 total ($149.50 average per 4 weeks), not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota or Mississippi; medication, provider consultation and shipping included, no subscription or membership fees; pay only if a provider prescribes; "8-week program $299 $149.50 average per 4 weeks" ($149.50 per 4 weeks on the 8-week program, $299 total; "The $299 8-week tirzepatide program is not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota, or Mississippi."). Gimme Care, compounded tirzepatide injection: $199/28 days, its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in".

When were Fifty 410 and Gimme Care prices last checked?

Prices checked Nov 11, 2026, Nov 13, 2026, and Nov 14, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Every sourced offer

All Fifty 410 and Gimme Care offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

4 current prices

Lowest starting 30-day cost ·

  • View
    $160/28 days (gimme.care/treatments/compounded-semaglutide)

    ≈ $171.43 per 30 days

    Checked on gimme.care

    Top dose: same price at 2.4 mg

    Terms & source

    Advertised price: month-to-month plan shipped every 28 days; $130/mo on a 3-month plan (billed every 3 months) or $119/mo on 6 months; the same price at every dose; consultation, care, medication, supplies, shipping and support included

    28-day supply (gimme.care)

    ≈ $171.43 per 30 days at this quoted rate

    Other plan lengths

    • $130/mo on 3 months
    • $119/mo on 6 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 2.4 mg.

    Weekly injection. Subscriptions renew at the same frequency until cancelled; shipped medication is non-refundable. A video or audio visit is required first in Kansas, Louisiana, Mississippi, New Mexico and West Virginia. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (gimme.care)
  • View
    $199/4 weeks (fifty410.com/pricing/semaglutide)

    ≈ $213.21 per 30 days

    Checked on fifty410.com

    Top dose: same price at 2.4 mg

    Terms & source

    Advertised price: 4-week program, $199 total, available in all 50 states; pay only if a provider prescribes, no subscription or membership fee; free overnight or 2-day shipping included; a "Clinician-guided" dose schedule; the page a visitor sees does not say whether higher doses cost more (its only line on that sits in the page's search-engine data, not on the page, read 7 Nov 2026); the same price at every dose: "all dosages are included in your $199 total for 4 weeks program price"

    28-day supply (fifty410.com)

    ≈ $213.21 per 30 days at this quoted rate

    Top-dose terms: The seller states one price at every dose, so this is also its price at 2.4 mg.

    Its page says "Administered as prescribed". Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (fifty410.com)
  • View
    $199/4 weeks (fifty410.com/pricing/tirzepatide)

    ≈ $213.21 per 30 days

    Checked on fifty410.com

    Top dose: No separate price on record

    Terms & source

    Advertised price: 4-week program, $199 total, available in all 50 states; an 8-week program is $299 total ($149.50 average per 4 weeks), not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota or Mississippi; medication, provider consultation and shipping included, no subscription or membership fees; pay only if a provider prescribes; "8-week program $299 $149.50 average per 4 weeks" ($149.50 per 4 weeks on the 8-week program, $299 total; "The $299 8-week tirzepatide program is not available in Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota, or Mississippi.")

    28-day supply (fifty410.com)

    ≈ $213.21 per 30 days at this quoted rate

    Other plan lengths

    • $149.50/28 days on 2 months ($299 up front)

    Its page says "Administered as prescribed" on a "Clinician-guided" dose schedule. Until late October the page sold 3-month Starter, Mid-dose and High-dose programs ($399, $499 and $549); its pages now show only the 4- and 8-week programs. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (fifty410.com)
  • View
    $199/28 days (gimme.care/treatments/compounded-tirzepatide)

    ≈ $213.21 per 30 days

    Checked on gimme.care

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: its plan table reads "Billing cycle Per month" with "1 month $ 199", "3 month $ 163" and "6 month $ 149" ($163/mo on 3 months, $149/mo on 6 months); "Same price at every dose"; "Shipped every 28 days after a short check-in"

    28-day supply (gimme.care)

    ≈ $213.21 per 30 days at this quoted rate

    Other plan lengths

    • $163/mo on 3 months
    • $149/mo on 6 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. The tirzepatide page does not say how the 3 and 6 month plans are billed. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (gimme.care)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How prices are compared, what FDA says about compounding

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

Public record

Fifty 410 vs Gimme Care: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

Fifty 410

Trustpilot 4.7 from 6,755 reviews. The BBB rates Fifty 410 F, with 21 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent Fifty 410 a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("clinically proven ingredients") were on none of the 3 pages of fifty410.com we read on Nov 16, 2026; fifty410.com now says "Compounded semaglutide and tirzepatide are not FDA-approved, and FDA has not reviewed them for safety, effectiveness or quality".

Is Fifty 410 legit?

Gimme Care

Trustpilot 4.3 from 2,056 reviews. We found no BBB profile that names Gimme Care's site. We found no FDA warning letter naming Gimme Care as of Nov 6, 2026.

Is Gimme Care legit?

Seller pages re-read automatically : 4 of 4 opened and checked for price changes. How prices stay current

Updated automatically

Fifty 410 and Gimme Care price changes

  • Seller recordFifty 410: updated record on its public ratings and records
  • Seller recordFifty 410: updated record on HSA and FSA cards (read on fifty410.com)
  • Seller recordFifty 410: record on taking insurance removed
  • Seller recordGimme Care: updated record on who makes its medicine (read on gimme.care)
  • Seller recordFifty 410: updated record on its public ratings and records
  • PriceFifty 410: Compounded tirzepatide via Fifty 410 now $199/4 weeks (was $133/mo) (read on fifty410.com)

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.